Our CEO Dr. Vlad Coric sat down with Jim Cramer and Mad Money On CNBC to talk about our phase two #Alzheimers Disease drug and our investigational novel anti #migraine medication. Watch the interview here and see how these drugs could impact the future ow.ly/ie0i50xB1jv #BHVN

Tips for surviving the #holidays with a neurologic condition. bit.ly/2S8atw4 #BrainandLife #HolidaySurvival #Neurology

#Ataxia people more at risk, Schmahmann Lab provided a key meeting to support groups. To learn more youtu.be/c-ic6Wn9m0Q @BiohavenPharma MGH Neurology

Our coordinator is conducting a research study for a new cognitive assessment scale for children. We're in search of families with children aged 3-17 to participate. If interested, please use the link below to reach out for more information. rally.partners.org/study/healthyc…

The #WEGOHealthAwards are open! I'd be honored to have your support wegohealth.com/97746845/awards

Great new research study opportunity!

#2022AAC. Are you ready! Almost time to kick off this years virtual AAC! Hope I see you there!

virtual.simplebooth.com/N2Sa6eKMoq8K/p… $2022AAC. I'm ready!!

#2022AAC. Welcome to over 700 registered participants in attendance today! 42 states! 19 countries! 278 first timers!

On deck - the Birds of a Feather Sessions!! Starting in 40 mins. #2022AAC #2022aac National Ataxia Foundation

virtual.simplebooth.com/N2Sa6eKMoq8K/p… #2022AAC. DAY 2 ALMOST GO TIME!!!

#2022AAC. Some really good hacks to make living with Ataxia a little easier! #2022aac National Ataxia Foundation

virtual.simplebooth.com/N2Sa6eKMoq8K/p… #2022AAC Ready for the Spouses/parnters affiliation group! Hope to see you there

Great way to kick off Day 1. #aac2023

Almost “Go” time! #aac2023

Learning from Bill Nye #aac2023

Recently the FDA refused to review Biohaven’s SCA3 filing. Dana Mauro, Host of 'Did You Know' Podcast and wife of person living with Ataxia responds  visit ataxia.org to submit a comment as well.#beheardSCA

NAF calls on the FDA to apply regulatory flexibility & accept the NDA for troriluzole. The SCA community deserves to be heard & learn whether this treatment meets the criteria for approval. We want to represent your voice! Tell us what you think: surveymonkey.com/r/9KWPTBR

95% of rare diseases have no treatment. Cameryn’s courageous story reminds us what is at stake. Share Cameryn’s story. #ataxia #KnowAtaxia #RareDisease

SCA is a devastating and fatal disease. Patients urgently need access to a treatment. Troriluzole is under review - we must urge FDA to approve Troriluzole now! Repost/share/comment Tag FDA and Dr. Marty Makary . Stronger together youtu.be/lmY8Gp9SwmU?si… via YouTube